The present disclosure provides medical devices possessing reactants thereon, which further promote adherence of the device to tissue in vivo and/or release of bioactive agents from the device.
대표청구항▼
1. A medical implant comprising: a mesh comprising a first reactant and at least one bioactive agent; anda fastener for securing the mesh to tissue, the fastener comprising a second reactant,wherein the second reactant degrades the first reactant, thereby releasing the bioactive agent in vivo. 2. Th
1. A medical implant comprising: a mesh comprising a first reactant and at least one bioactive agent; anda fastener for securing the mesh to tissue, the fastener comprising a second reactant,wherein the second reactant degrades the first reactant, thereby releasing the bioactive agent in vivo. 2. The medical implant according to claim 1, wherein the fastener is selected from the group consisting of staples, sutures, clips, tacks, screws, pins and anchors. 3. The medical implant according to claim 1, wherein the first reactant comprises hydrolytically degradable bonds and the second reactant comprises an acid. 4. The medical implant according to claim 3, wherein the acid adjusts the pH of bodily fluid adjacent the medical implant to a pH from about 5 to about 7.5. 5. The medical implant according to claim 3, wherein the first reactant comprises a polymer possessing monomers selected from the group consisting of lactic acid, glycolic acid, lactide, glycolide, ε-caprolactone, trimethylene carbonate, dioxanones, azelaic acid, succinnic acid, adipic acid, sebacic acid, malonic acid, glutaric acid, ethyl dichlorophosphate, azelaic acid anhydride, sebacic acid anhydride, and combinations thereof. 6. The medical implant according to claim 3, wherein the second reactant is an acid selected from the group consisting of lactic acid, citric acid, acetic acid, stearic acid, salicylic acid, and combinations thereof. 7. The medical implant according to claim 3, wherein the second reactant comprises a polymer having acid functional groups thereon, the acid functional groups selected from the group consisting of carboxylic acids, sulfonic acids, and combinations thereof. 8. The medical implant according to claim 1, wherein the first reactant comprises hydrolytically degradable bonds and the second reactant comprises a base. 9. The medical implant according to claim 8, wherein the base adjusts the pH of bodily fluid adjacent the medical implant to a pH from about 7.5 to about 9.5. 10. The medical implant according to claim 1, wherein the first reactant comprises enzymatically degradable linkages and the second reactant comprises an enzyme. 11. The medical implant according to claim 10, wherein the enzymatically degradable linkages comprise peptidic linkages, and the enzyme is selected form the group consisting of proteases, metalloproteinases, collagenases, and combinations thereof. 12. The medical implant according to claim 10, wherein the enzymatically degradable linkages are selected from the group consisting of amino acid residues, 2-mer to 6-mer oligopeptides, D-glucose, N-acetylgalactosamine, N-acetylneuraminic acid, N-acetylglucosamine, N-acetylmannnosamine, oligodeoxyadenine, oligodeoxyguanine, oligodeoxycytosine, oligodeoxythymidine; oligoadenine, oligoguanine, oligocytosine, oligouridine, and combinations thereof. 13. The medical implant according to claim 1, wherein the bioactive agent is selected from the group consisting of proteins, analgesics, growth factors, chemotherapeutics, and combinations thereof. 14. A medical implant comprising: a mesh comprising a first reactant and at least one bioactive agent; anda component for securing the mesh to tissue comprising a second reactant, the component selected from the group consisting of staples, sutures, clips, tacks, screws, pins, anchors, and fasteners,wherein the second reactant degrades the first reactant, thereby releasing the bioactive agent in vivo. 15. The medical implant according to claim 14, wherein the first reactant comprises hydrolytically degradable bonds and the second reactant comprises an acid. 16. The medical implant according to claim 15, wherein the acid adjusts the pH of bodily fluid adjacent the medical implant to a pH from about 5 to about 7.5. 17. The medical implant according to claim 15, wherein the first reactant comprises a polymer possessing monomers selected from the group consisting of lactic acid, glycolic acid, lactide, glycolide, ε-caprolactone, trimethylene carbonate, dioxanones, azelaic acid, succinnic acid, adipic acid, sebacic acid, malonic acid, glutaric acid, ethyl dichlorophosphate, azelaic acid anhydride, sebacic acid anhydride, and combinations thereof. 18. The medical implant according to claim 15, wherein the second reactant is an acid selected from the group consisting of lactic acid, citric acid, acetic acid, stearic acid, salicylic acid, and combinations thereof. 19. The medical implant according to claim 15, wherein the second reactant comprises a polymer having acid functional groups thereon, the acid functional groups selected from the group consisting of carboxylic acids, sulfonic acids, and combinations thereof. 20. The medical implant according to claim 14, wherein the first reactant comprises hydrolytically degradable bonds and the second reactant comprises a base. 21. The medical implant according to claim 20, wherein the base adjusts the pH of bodily fluid adjacent the medical implant to a pH from about 7.5 to about 9.5. 22. The medical implant according to claim 14, wherein the first reactant comprises enzymatically degradable linkages and the second reactant comprises an enzyme. 23. The medical implant according to claim 22, wherein the enzymatically degradable linkages comprise peptidic linkages, and the enzyme is selected form the group consisting of proteases, metalloproteinases, collagenases, and combinations thereof. 24. The medical implant according to claim 22, wherein the enzymatically degradable linkages are selected from the group consisting of amino acid residues, 2-mer to 6-mer oligopeptides, D-glucose, N-acetylgalactosamine, N-acetylneuraminic acid, N-acetylglucosamine, N-acetylmannnosamine, oligodeoxyadenine, oligodeoxyguanine, oligodeoxycytosine, oligodeoxythymidine; oligoadenine, oligoguanine, oligocytosine, oligouridine, and combinations thereof. 25. The medical implant according to claim 14, wherein the bioactive agent is selected from the group consisting of proteins, analgesics, growth factors, chemotherapeutics, and combinations thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (29)
Green David T. (Westport CT) Bolanos Henry (East Norwalk CT) Alesi Daniel E. (New Fairfield CT) Ratcliff Keith (Sandy Hook CT) Sherts Charles R. (Southport CT), Apparatus and method for placing staples in laparoscopic or endoscopic procedures.
Green David T. (Westport CT) Bolanos Henry (East Norwalk CT) Alesi Daniel E. (New Fairfield CT) Ratcliff Keith (Sandy Hook CT) Sherts Charles R. (Southport CT), Apparatus and method for placing staples in laparoscopic or endoscopic procedures.
Donald G. Wallace ; George H. Chu ; Jacqueline Anne Schroeder, Compositions and systems for forming high strength medical sealants, and associated methods of preparation and use.
Chu George H. ; Yeung Jeff E. ; Schroeder Jacqueline Anne ; Shenoy Vivek N. ; Brown Melissa K. C. ; Cassidy James J. ; Rice John, Devices for tissue repair and methods for preparation and use thereof.
Olson Todd (Loveland OH) Meiser Dan (Oxford OH) Steed Gary (Cleves OH) Huffman Eric (Loveland OH) Otten Matthew (Cincinnati OH) VanOverloop Ronald (West Chester OH) Powell Darrel (Cincinnati OH) Knod, Linear stapling mechanism with cutting means.
Robinson Stephen C. (Cincinnati OH) Olson Todd (Loveland OH) Meiser Dan (Butler KY) Steed Gary (Cleves OH) Huffman Eric (Loveland OH) Otten Matthew (Cincinnati OH) VanOverloop Ronald (West Chester OH, Linear stapling mechanism with cutting means.
Green David T. (Westport CT) Ratcliff Keith (Sandy Hook CT) Milliman Keith L. (Norwalk CT) Sienkiewicz Henry R. (Stamford CT) Palmer Mitchell J. (New Milford CT), Self contained gas powered surgical apparatus.
Green David T. (Westport CT) Sienkiewicz Henry R. (Stamford CT) McClure Richard C. (Monroe CT) Savage Robert C. (Stratford CT) Milliman Keith L. (Norwalk CT) Palmer Mitchell J. (New Milford CT) Heato, Self contained gas powered surgical apparatus.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.